ANTIFUNGAL RESISTANCE IN CANDIDA SPECIES ISOLATED FROM PATIENTS PRESENTING WITH VULVOVAGINAL CANDIDIASIS DURING DIFFERENT TRIMESTERS OF PREGNANCY

Main Article Content

Ronaq Zaman
Ihsan Ullah
Ambreen Arif

Keywords

Broth microdilution, Fluconazole, Itraconazole, Clotrimazole, Voriconazole, Miconazole

Abstract

The aim of this study was to assess frequency of Candida species causing vulvovaginal candidiasis among symptomatic pregnant females and their resistance pattern against azoles antifungal drugs. Specimens were taken from 176 antenatal patients having signs and symptoms of vulvovaginal candidiasis. Culture, microscopic examination and API 20C AUX system were used for isolation and identification of Candida species. Susceptibility testing to Azoles were performed by disc diffusion and broth microdilution method. Out of 176 samples, 73(43%) were positive for Candida infection. Candida albican were 31(42.4%) followed by Candida krusei 20(27.3%), Candida parapsilosis 18(24.6%) and Candida glabrata (5.4%). Candida infection was more frequent in 2nd trimester (54.7%) followed by 3rd trimester (27.3%) and 1st trimester 13(17.8%). A good agreement was revealed between the disc diffusion and broth microdilution methods in detecting resistance in Candida species. Nonalbicans Candida showed higher resistance against Fluconazole (P-value <0.001), Clotrimazole (P-value 0.03) and Miconazole (P-value 0.01) as compared to C. albicans. It is necessary to perform antifungal susceptibility tests for Candida species for providing resistance profile information to choose appropriate drug for treatment. Disc diffusion method can be used in diagnostic practice as it is convenient to perform.

Abstract 232 | pdf Downloads 154

References

1. Anh DN, Hung DN, Tien TV, et al. Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam. BMC Infec Dis. 2021;21(1):523.
2. Disha T, Haque F . Prevalence and risk factors of vulvovaginal candidosis during pregnancy: a review. Infect Dis Obstet Gynecol. 2022;2022:6195712.
3. Venugopal D, Husain K, Mustafa S, etal. Epidemiology, risk factors and antimicrobial profile of Vulvovaginal Candidiasis (VVC): A study among women in the central region of Saudi Arabia. J Mycol Med. 2021;31(2):101049.
4. Kumar M, Saadaoui M, Al Khodor S, . Infections and pregnancy: Effects on maternal and child health. Front Cell Infect Microbiol. 2022;12: 873253.
5. Ghaddar N, Anastasiadis E, Halimeh R, et al. Prevalence and antifungal susceptibility of Candida albicans causing vaginal discharge among pregnant women in Lebanon. BMC Infec Dis .2020;20(1):1-9.
6. Waikhom SD, Afeke I, Kwawu GS, et al. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates. BMC Pregnancy childbirth. 2020;20:1-14.
7. Jaqueti Aroca J, Ramiro Martínez P, etal. Epidemiología y etiología de la candidiasis vaginal en mujeres españolas e inmigrantes en Fuenlabrada (Madrid) [Epidemiology and etiology of vulvovaginal candidiasis in Spanish and immigrants' women in Fuenlabrada (Madrid)]. Rev Esp Quimioter. 2020 Jun;33(3):187-192.
8. Zhai Y, Liu J, Zhou L, etal. Detection of Candida species in pregnant Chinese women with a molecular beacon method. J Med Microbiol. 2018 Jun;67(6):783-789.
9. Khan F, Baqai R. In vitro antifungal sensitivity of fluconazole, clotrimazole and nystatin against vaginal candidiasis in females of childbearing age. J Ayub Med Coll Abbotabad. 2010;22(4):197-200.
10. Paul S, Kannan I. Molecular identification and antifungal susceptibility pattern of Candida species isolated from HIV infected Patients with candisiasis.Curr Med Mycol. 2019;5(1):21.
11. Costa C, Ribeiro J, Miranda IM, etal. Clotrimazole Drug Resistance in Candida glabrata Clinical Isolates Correlates with Increased Expression of the Drug:H(+) Antiporters CgAqr1, CgTpo1_1, CgTpo3, and CgQdr2. Front Microbiol. 2016 Apr 19;7:526
12. Morishige H, Mano Y, Oguri T, etal Comparison of four reading methods of broth microdilution based on the clinical and laboratory standards institute M27-A3 method for Candida spp. Jpn J Antibiot. 2012 Oct;65(5):335-47.
13. Ibrahim SM, Bukar M, Mohammed Y, etal. Prevalence of vaginal candidiasis among pregnant women with abnormal vaginal discharge in Maiduguri. Niger J Med. 2013 Apr-Jun;22(2):138-42.
14. Tasneem U, Siddiqui MT, Faryal R, etal. Prevalence and antifungal susceptibility of Candida species in a tertiary care hospital in Islamabad, Pakistan. J Pak Med Assoc. 2017;67(7):986-91.
15. Parveen N, Munir AA, Din I, etal . Frequency of vaginal candidiasis in pregnant women attending routine antenatal clinic. J Coll Physicians Surg Pak. 2008 Mar;18(3):154-7
16. Konadu DG, Owusu-Ofori A, Yidana Z, et al. Prevalence of vulvovaginal candidiasis, bacterial vaginosis and trichomoniasis in pregnant women attending antenatal clinic in the middle belt of Ghana. BMC Pregnancy childbirth. 2019;19(1):1-10.
17. Khan M, Ahmed J, Gul A, etal. Antifungal susceptibility testing of vulvovaginal Candida species among women attending antenatal clinic in tertiary care hospitals of Peshawar. Infect drug resis. 2018;11:447-56
18. Mucci MJ, Cuestas ML, Cervetto MM, etal. A prospective observational study of vulvovagintis in pregnant women in Argentina, with special reference to candidiasis. Mycoses. 2016 Jul;59(7):429-35.
19. Kan S, Song N, Pang Q, etal. In Vitro Antifungal Activity of Azoles and Other Antifungal Agents Against Pathogenic Yeasts from Vulvovaginal Candidiasis in China. Mycopathologia. 2023 Apr;188(1-2):99-109.
20 Sangaré I, Sirima C, Bamba S, etal. Prevalence of vulvovaginal candidiasis in pregnancy at three health centers in Burkina Faso. J Mycol Med. 2018 Mar;28(1):186-192.
21. Zida A, Yacouba A, Bamba S, etal. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso). J Mycol Med. 2017 Dec;27(4):469-475
22. KuMar D, Bhattacharyya S, Gupta P, etal. Comparative analysis of disc diffusion and E-test with broth micro-dilution for susceptibility testing of clinical Candida isolates against amphotericin B, fluconazole, voriconazole and caspofungin. J clin diagn res. 2015;9(11):DC01.
23. Bashir G, Altaf I, Khurshid R, etal. Identification and pattern of antifungal susceptibility of Candida species isolated from cases of vaginitis in a tertiary care hospital in India. Iran J Microbiol. 2023 Apr;15(2):318-324.